{
  "meta": {
    "title": "Communicable_Disease_Vector-Borne_Disease_Part1",
    "url": "https://brainandscalpel.vercel.app/communicable-disease-vector-borne-disease-part1-18ce53e7.html",
    "scrapedAt": "2025-11-30T11:18:29.968Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Hard tick</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Soft tick</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Mite</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Mosquito</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Vector involved in Crimean-Congo haemorrhagic fever (CCHF) is:</span></p>",
      "unique_key": "DT1231364",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231364,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>CCHF is caused by the <strong>Crimean-Congo hemorrhagic fever virus (CCHFV)</strong>, and the primary vector is the <strong>hard tick</strong>, especially of the genus Hyalomma. These ticks transmit the virus to humans through bites or by crushing infected ticks.</p>\r\n<ul>\r\n<li><strong>Causative agent:</strong> Crimean-Congo hemorrhagic fever virus (CCHFV) - a Nairovirus.</li>\r\n<li><strong>Vector:</strong> Hard ticks (Hyalomma spp.) are the main reservoir and vector.</li>\r\n<li><strong>Mode of transmission:</strong> Tick bite, direct contact with blood/tissues of infected animals or humans.</li>\r\n<li><strong>Epidemiological note:</strong> Hard ticks can survive prolonged starvation and remain attached to the host for days, aiding in transmission.</li>\r\n<li><strong>Public health importance of hard ticks:</strong>\r\n<ul>\r\n<li>Tick typhus (Rocky Mountain spotted fever)</li>\r\n<li>Viral encephalitis (e.g., Russian spring-summer encephalitis)</li>\r\n<li>Viral haemorrhagic fevers (e.g., CCHF, KFD in India)</li>\r\n<li>Tularemia</li>\r\n<li>Tick paralysis</li>\r\n<li>Human babesiosis</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Soft tick (Option B):</strong> Can transmit relapsing fever but <strong>not</strong> CCHF.</p>\r\n<p><strong>Mite (Option C):</strong> Vector for scrub typhus (Orientia tsutsugamushi), not for CCHF.</p>\r\n<p><strong>Mosquito (Option D):</strong> Vector for malaria, dengue, chikungunya, Zika - not implicated in CCHF transmission.</p>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Nipah virus causes encephalitis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be transmitted to humans from animals</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Human-to-human transmission is present</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Pigs are the natural host</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All the following are true regarding Nipah virus infection except:</span></p>",
      "unique_key": "DT1231367",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231367,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Fruit bats of the family <strong>Pteropodidae</strong>, particularly genus <strong>Pteropus</strong>, are the <strong>natural reservoir</strong> of Nipah virus. Pigs can act as intermediate hosts and amplifying hosts, but they are <strong>not</strong> the natural host. Nipah virus causes severe encephalitis and can spread from animals to humans and between humans through close contact.</p>\r\n<p><strong>Nipah Virus:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925c55209a4-25ab-4a33-b79a-56bc9149fdcd.png\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Nipah virus causes encephalitis (Option A):</strong> True, the disease commonly presents with severe encephalitis, often with respiratory features and high fatality.</p>\r\n<p><strong>Can be transmitted to humans from animals (Option B):</strong> True, spillover to humans occurs from infected fruit bats and from pigs through close contact/contaminated secretions.</p>\r\n<p><strong>Human to human transmission is present (Option C):</strong> True, transmission among close contacts and in healthcare settings is documented.</p>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Fruit bat is the amplifying host</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Human transmission possible</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Pigs die of the disease</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Causes encephalitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">False about Nipah Virus:</span></p>",
      "unique_key": "DT1231370",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231370,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Fruit bats of the genus Pteropus are the <strong>natural reservoir hosts</strong>, not amplifying hosts. They carry Nipah virus asymptomatically and shed it through urine, saliva, and excreta. Amplifying hosts are species in which the virus multiplies to high levels and can spread efficiently to other susceptible hosts, such as pigs.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Human transmission possible (Option B):</strong> True, Nipah virus can spread from animals to humans and also between humans through close contact with infected individuals or their bodily fluids.</p>\r\n<p><strong>Pigs die of the disease (Option C):</strong> True, Pigs can develop severe respiratory and neurological disease with high mortality, acting as important amplifying hosts.</p>\r\n<p><strong>Causes encephalitis (Option D):</strong> True, In humans, Nipah virus can cause acute encephalitis with high case fatality, often presenting with fever, headache, dizziness, drowsiness, and neurological signs.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Mosquito transmitted</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Flavi viridae</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Nosocomial infection</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct contact</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True about Ebola is:</span></p>",
      "unique_key": "DT1231375",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Ebola virus is primarily transmitted through <strong>direct contact</strong> with blood, body fluids, or tissues of infected individuals or animals, via broken skin or mucous membranes. Contaminated objects or surfaces can also serve as sources of infection if they are tainted with infectious body fluids.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Mosquito transmitted (Option A):</strong> Incorrect, Ebola virus is not transmitted by mosquitoes; there is no evidence of mosquito-borne spread.</p>\r\n<p><strong>Flavi viridae (Option B):</strong> Incorrect, Ebola virus belongs to the family <em>Filoviridae</em>, not Flaviviridae.</p>\r\n<p><strong>Nosocomial infection (Option C):</strong> Incorrect, While Ebola can spread in healthcare settings (nosocomial spread), this is not its primary mode of transmission; direct contact remains the main route.</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Culex</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Aedes aegypti</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Sandfly</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Louse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Vector of Zika Virus:</span></p>",
      "unique_key": "DT1231379",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231379,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Aedes aegypti</strong> is the primary vector for <strong>Zika virus</strong> transmission. This mosquito is also responsible for spreading <strong>dengue</strong> and <strong>chikungunya</strong> in tropical and subtropical regions.</p>\r\n<ul>\r\n<li><strong>Zika virus</strong> is a mosquito-borne flavivirus first identified in <strong>Uganda</strong> in 1947 in monkeys.</li>\r\n<li>The first large outbreak in humans was reported from the <strong>island of Yap</strong> in 2007.</li>\r\n<li>Transmission occurs mainly through the bite of infected mosquitoes belonging to the <strong>Aedes genus</strong>, particularly <strong>Aedes aegypti</strong>, and to a lesser extent, <strong>Aedes albopictus</strong>.</li>\r\n<li>These mosquitoes are aggressive <strong>daytime biters</strong>, with peak feeding during early morning and late afternoon.</li>\r\n<li>The virus can also be transmitted <strong>vertically</strong> (mother to child during pregnancy), through <strong>sexual contact</strong>, and via <strong>blood transfusion</strong>.</li>\r\n<li>Clinical presentation includes <strong>mild fever</strong>, <strong>rash</strong>, <strong>conjunctivitis</strong>, <strong>arthralgia</strong>, and <strong>headache</strong>. Many infections are <strong>asymptomatic</strong>.</li>\r\n<li>Complications include <strong>Guillain-Barr&eacute; syndrome</strong> and <strong>congenital Zika syndrome</strong> in infants born to infected mothers.</li>\r\n<li>Diagnosis is confirmed by <strong>PCR</strong> or <strong>virus isolation</strong> from blood samples; <strong>serology</strong> is not routinely recommended.</li>\r\n<li>Prevention focuses on <strong>vector control</strong> - reducing mosquito breeding sites, <strong>personal protection measures</strong> (bed nets, repellents, clothing coverage), and <strong>community awareness </strong>campaigns.</li>\r\n<li>Currently, there is <strong>no specific antiviral treatment</strong> or <strong>commercially available vaccine</strong> for the Zika virus.</li>\r\n<li>Control strategies are integrated with those for other Aedes-borne diseases due to the overlapping <strong>vector ecology</strong>.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Culex (Option A):</strong> Culex mosquitoes transmit diseases such as <strong>West Nile virus</strong> and <strong>filariasis</strong>; they are not vectors for Zika virus.</p>\r\n<p><strong>Sandfly (Option C):</strong> Sandflies are vectors for <strong>leishmaniasis</strong>, not for Zika virus transmission.</p>\r\n<p><strong>Louse (Option D):</strong> Lice transmit <strong>typhus</strong> and <strong>trench fever</strong>; they do not play a role in Zika virus spread.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Crimean-Congo</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Marburg</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Ebola</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Yellow fever</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Viral haemorrhagic fever confirmed in India?</span></p>",
      "unique_key": "DT1231381",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231381,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Crimean-Congo haemorrhagic fever (CCHF)</strong> is the only viral haemorrhagic fever that has been <strong>confirmed in India</strong>. It is caused by the Crimean-Congo haemorrhagic fever virus (CCHFV) and is transmitted mainly through <strong>tick bites</strong> or <strong>direct contact with blood/tissues</strong> of infected livestock or humans. Sporadic human cases have been reported in certain states, making it a public health concern.</p>\r\n<ul>\r\n<li><strong>Agent:</strong> Crimean-Congo haemorrhagic fever virus (family Bunyaviridae).</li>\r\n<li><strong>Transmission:</strong> Bite of infected Hyalomma ticks; contact with blood/tissues of infected animals; possible human-to-human transmission via contact with infectious body fluids.</li>\r\n<li><strong>Clinical features:</strong> Sudden onset of fever, myalgia, dizziness, neck pain, and stiffness, followed by haemorrhagic manifestations.</li>\r\n<li><strong>Epidemiology in India:</strong> Cases documented in Gujarat and Rajasthan, highlighting the zoonotic nature and occupational risk for farmers, veterinarians, and slaughterhouse workers.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Marburg (Option B):</strong> Caused by Marburg virus (family Filoviridae); outbreaks reported in parts of Africa, but <strong>no confirmed cases in India</strong>.</p>\r\n<p><strong>Ebola (Option C):</strong> Caused by Ebola virus (family Filoviridae); major outbreaks in Africa, but <strong>no confirmed cases in India</strong>.</p>\r\n<p><strong>Yellow fever (Option D):</strong> Caused by the yellow fever virus (family Flaviviridae); transmitted by Aedes aegypti; endemic in Africa and South America, but <strong>never reported in India</strong>.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Artemisinin</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate Combination Therapy</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">First-line antimalarial drug for the treatment of Plasmodium falciparum:</span></p>",
      "unique_key": "DT1231392",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231392,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Artesunate Combination Therapy (ACT)</strong> is the first-line treatment for uncomplicated P. falciparum malaria as per the <strong>National Vector Borne Disease Control Programme (NVBDCP)</strong> and <strong>WHO</strong> guidelines. ACT rapidly reduces parasite load and prevents resistance by combining an artemisinin derivative with a partner drug.</p>\r\n<ul>\r\n<li><strong>Rationale for ACT:</strong>\r\n<ul>\r\n<li>P. falciparum has developed <strong>widespread chloroquine resistance</strong>, making older regimens ineffective.</li>\r\n<li>Artemisinin derivatives provide <strong>rapid parasite clearance</strong>, while the partner drug ensures complete eradication and prevents recrudescence.</li>\r\n<li>In <strong>North-Eastern states of India</strong>: ACT-AL (Artemether + Lumefantrine) is preferred.</li>\r\n<li>In <strong>other states</strong>: ACT-SP (Artesunate + Sulfadoxine-Pyrimethamine) is used.</li>\r\n<li>A <strong>single dose of primaquine</strong> (0.75 mg/kg) is added on the 2nd day to block transmission by killing gametocytes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>WHO/NVBDCP Recommendations:</strong>\r\n<ul>\r\n<li>First-line therapy for uncomplicated falciparum malaria = ACT.</li>\r\n<li>Avoid artemisinin monotherapy to prevent <strong>drug resistance</strong>.</li>\r\n<li>Severe P. falciparum malaria is treated with <strong>intravenous artesunate</strong> followed by a complete oral ACT course.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925a061fd7f-bee4-457a-9ea9-1376140dae02.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Primaquine (Option A):</strong> Used mainly for P. vivax and P. ovale to eradicate <strong>hypnozoites</strong> and prevent relapse; in P. falciparum malaria, only a single <strong>gametocytocidal</strong> dose is given, not as first-line treatment.</p>\r\n<p><strong>Artemisinin (Option B):</strong> Highly effective and fast-acting, but never used alone; always part of <strong>ACT</strong> to prevent <strong>drug resistance</strong>.</p>\r\n<p><strong>Chloroquine (Option D):</strong> Once first-line for malaria, but now ineffective for P. falciparum in most areas due to <strong>widespread resistance</strong>.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">3 days</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">5 days</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">10 days</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">14 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In Plasmodium vivax malaria, the drug primaquine is given for a period of:</span></p>",
      "unique_key": "DT1231393",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231393,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Primaquine for 14 days</strong> is recommended in P. vivax malaria to eradicate <strong>hypnozoites</strong>, the dormant liver-stage forms responsible for relapse. This <strong>radical cure</strong> prevents the recurrence of malaria after initial treatment with chloroquine.</p>\r\n<ul>\r\n<li>P. vivax has a <strong>hepatic dormant stage</strong> (hypnozoites) that can remain latent and cause relapses months after initial infection.</li>\r\n<li><strong>Chloroquine</strong> clears the blood-stage parasites, while <strong>primaquine</strong> targets liver hypnozoites.</li>\r\n<li>The standard regimen is <strong>Primaquine 0.25 mg/kg daily for 14 days</strong> (contraindicated in G6PD deficiency and pregnancy).</li>\r\n<li>Shorter courses (3, 5, or 10 days) are insufficient to completely clear hypnozoites and prevent relapse.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925204fe8a5-8f64-4e59-b757-5c5a6a5af386.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>3 days (Option A):</strong> Insufficient duration; does not fully eliminate hypnozoites, leading to high relapse rates.</p>\r\n<p><strong>5 days (Option B):</strong> Still inadequate for radical cure; hypnozoites may persist in the liver.</p>\r\n<p><strong>10 days (Option C):</strong> Longer than 3 or 5 days but still less effective than 14 days in preventing relapses.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral quinine</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral artemisinin</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Either parenteral quinine or parenteral artemisinin</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Mefloquine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug of choice for severe and complicated Plasmodium falciparum malaria:</span></p>",
      "unique_key": "DT1231396",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231396,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Either parenteral quinine or parenteral artemisinin</strong> is recommended for the treatment of <strong>severe and complicated P. falciparum malaria</strong>. WHO guidelines emphasise that <strong>intravenous artesunate</strong> is the preferred option due to better survival outcomes and rapid parasite clearance, but <strong>quinine</strong> remains a valid alternative where artemisinin derivatives are unavailable.</p>\r\n<ul>\r\n<li>Severe malaria is a medical emergency with high mortality; prompt initiation of parenteral therapy is essential.</li>\r\n<li><strong>Artemisinin derivatives</strong> (especially artesunate) act rapidly and reduce parasite biomass quickly, improving survival.</li>\r\n<li><strong>Quinine</strong> has been historically used and is still effective, especially in areas where artesunate is not accessible.</li>\r\n<li>After initial parenteral therapy and clinical improvement, patients are switched to a full course of an <strong>ACT (Artemisinin-based Combination Therapy)</strong> to complete treatment.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925d10c9941-ecf0-42c9-ac10-839eb9b1f96e.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Parenteral quinine (Option A):</strong> Effective alternative, but less preferred due to slower parasite clearance and higher side-effect profile compared to artesunate.</p>\r\n<p><strong>Parenteral artemisinin (Option B):</strong> Preferred option, but not the only recommended drug; quinine is also acceptable.</p>\r\n<p><strong>Mefloquine (Option D):</strong> Used for uncomplicated malaria; not recommended in severe cases due to delayed action and neuropsychiatric side effects.</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation of the virus</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of herd immunity</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Lack of efficient vector control activities</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Globalisation & emergence of Aedes albopictus in addition to Aedes aegypti</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following factor is/are responsible for the resurgence of Chikungunya except</span></p>",
      "unique_key": "DT1231397",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231397,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The resurgence of <strong>Chikungunya fever</strong> is influenced by multiple factors, including <strong>mutation of the virus</strong>, <strong>globalisation</strong>, and the <strong>emergence of Aedes albopictus</strong> in addition to Aedes aegypti. These factors enhance transmission and geographic spread. <strong>The presence of herd immunity</strong>, on the other hand, usually limits disease spread, making it the exception among the listed factors.</p>\r\n<ul>\r\n<li><strong>Resurgence Factors:</strong>\r\n<ul>\r\n<li><strong>Viral mutation:</strong> Increases vector adaptability and may enhance transmission efficiency.</li>\r\n<li><strong>Vector expansion:</strong> Spread of Aedes albopictus along with Aedes aegypti broadens endemic zones.</li>\r\n<li><strong>Globalisation:</strong> Increased travel and trade facilitate the introduction of the virus into new areas.</li>\r\n<li><strong>Climate factors:</strong> Favourable weather supports vector breeding.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Herd immunity:</strong> Population immunity, either post-infection or via vaccination, reduces susceptibility and generally prevents resurgence unless immunity wanes or new strains emerge.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Mutation of virus (Option A):</strong> Genetic changes can improve viral fitness and adaptability to different mosquito species, facilitating wider spread.</p>\r\n<p><strong>Lack of efficient vector control activities (Option C):</strong> Inadequate mosquito control directly contributes to increased vector density and sustained transmission.</p>\r\n<p><strong>Globalisation &amp; emergence of Aedes albopictus in addition to Aedes aegypti (Option D):</strong></p>\r\n<p>International travel and trade allow wider spread, while the presence of an additional competent vector expands the transmission potential.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium ovale</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium malariae</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium falciparum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The shortest incubation period in malaria is for -</span></p>",
      "unique_key": "DT1231399",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231399,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Plasmodium falciparum malaria has the shortest incubation period among human malaria species. The incubation period is typically 7-14 days, but it may be as short as 5 days under favourable conditions for parasite development.</p>\r\n<p><strong>Incubation period of different Plasmodium species</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509257a214a7b-02ba-480b-8338-83216f923d88.png\">\r\n<p><strong>(Other options ruled out)</strong></p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Anopheles stephensi</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Anopheles fluviatilis</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Anopheles culicifacies</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Anopheles sundaicus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The vector for malaria in hilly areas and forests is:</span></p>",
      "unique_key": "DT1231401",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231401,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Anopheles fluviatilis is the main vector responsible for malaria transmission in hilly areas and forested regions in India. This species prefers breeding in slow-moving streams, rivers, and clean foothill waters, making it well-adapted to such environments.</p>\r\n<ul>\r\n<li><strong>Habitat:</strong> Hilly and forest areas.</li>\r\n<li><strong>Breeding sites:</strong> Streams and rivers in foothill zones.</li>\r\n<li><strong>Role in malaria transmission:</strong> An Efficient malaria vector in these terrains.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509256b18e9c6-9d7b-4f08-aa99-4a594d6dd126.png\">\r\n<p><strong>(Other options ruled out)</strong></p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Spleen rate</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Infant parasite rate</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Parasite density index</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Slide positivity rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most sensitive index of recent transmission of malaria is -</span></p>",
      "unique_key": "DT1231403",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231403,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Infant parasite rate is the most sensitive index for recent malaria transmission because infants have no prior immunity, and any parasitemia detected in this group indicates <strong>very recent and ongoing transmission</strong>.</p>\r\n<ul>\r\n<li><strong>Definition:</strong> Percentage of infants (below 1 year of age) showing malaria parasites in a peripheral blood smear.</li>\r\n<li><strong>Reason for sensitivity:</strong>\r\n<ul>\r\n<li>Infants are immunologically naive to malaria.</li>\r\n<li>Any positive case reflects recent infection rather than past exposure.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Epidemiological significance:</strong>\r\n<ul>\r\n<li>Reliable measure for assessing recent malaria transmission in a locality.</li>\r\n<li>Useful in monitoring the success of malaria control programs.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Advantages:</strong>\r\n<ul>\r\n<li>Detects ongoing transmission even when other indices like spleen rate or slide positivity rate are low.</li>\r\n<li>Less influenced by past infections or acquired immunity.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Interpretation:</strong>\r\n<ul>\r\n<li>High infant parasite rate &rarr; active transmission and poor control measures.</li>\r\n<li>Low/zero infant parasite rate &rarr; effective malaria control or absence of recent transmission.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Spleen rate (Option A):</strong> Measures the percentage of children aged 2-10 years with an enlarged spleen. Good for assessing endemicity but not as sensitive for detecting recent transmission.</p>\r\n<p><strong>Parasite density index (Option C):</strong> Indicates the average number of malaria parasites per infected person. Reflects severity in individuals, not the timing of transmission in a community.</p>\r\n<p><strong>Slide positivity rate (Option D):</strong> Refers to the percentage of examined blood smears positive for malaria parasites. Useful for prevalence assessment but less sensitive than infant parasite rate for detecting recent transmission.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">0.1</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\"> 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a town with a a population of 1,00,000, the number of slides examined is 50,000. Out of these, 100 slides were positive for malaria. The API is -</span></p>",
      "unique_key": "DT1231405",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231405,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The Annual Parasite Index (API) is calculated as the number of confirmed malaria cases per 1,000 population in a year. In this case, the calculation gives an API of 1, indicating moderate malaria transmission.</p>\r\n<ul>\r\n<li><strong>Definition:</strong> API = (Confirmed malaria cases during one year &divide; Population under surveillance) &times; 1,000</li>\r\n<li><strong>Given:</strong>\r\n<ul>\r\n<li>Total population = 1,00,000</li>\r\n<li>Number of slides examined = 50,000</li>\r\n<li>Number of slides positive for malaria = 100</li>\r\n</ul>\r\n</li>\r\n<li><strong>Calculation:</strong>\r\n<ul>\r\n<li>API = (100 &divide; 1,00,000) &times; 1,000</li>\r\n<li>API = 1</li>\r\n</ul>\r\n</li>\r\n<li><strong>Epidemiological significance:</strong>\r\n<ul>\r\n<li><strong>API &ge; 2</strong> &rarr; classified as high-risk areas, eligible for intensified control measures.</li>\r\n<li><strong>API &lt; 2</strong> &rarr; lower transmission, but still requires active surveillance and control.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Uses:</strong>\r\n<ul>\r\n<li>Guides malaria control programme planning and resource allocation.</li>\r\n<li>Allows comparison of transmission intensity between different regions.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>0.1 (Option A):</strong> Would result if there were only 10 confirmed cases in the same population, indicating very low transmission.</p>\r\n<p><strong>0.5 (Option B):</strong> Would result from 50 confirmed cases in the population; still lower than the actual given scenario.</p>\r\n<p><strong>2 (Option D):</strong> Would indicate 200 confirmed cases in the population, which is double the actual case count.</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Annual parasite index</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Slide positivity rate</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Slide falciparum rate</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Annual blood examination rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Measurement of operational efficiency of NVBDCP is done by -</span></p>",
      "unique_key": "DT1231406",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231406,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The Annual Blood Examination Rate (ABER) is the proportion of the population whose blood slides are examined for malaria in a year. It reflects the coverage and reach of malaria diagnostic services. A higher ABER indicates better operational efficiency of NVBDCP as it shows that a larger section of the population is being tested for malaria, facilitating early detection and treatment.</p>\r\n<ul>\r\n<li><strong>Definition:</strong>\r\n<ul>\r\n<li>ABER = (Number of blood slides examined / Total population) &times; 100</li>\r\n</ul>\r\n</li>\r\n<li><strong>Purpose:</strong>\r\n<ul>\r\n<li>Monitors operational performance of malaria control activities.</li>\r\n<li>Ensures adequate surveillance coverage.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Target:</strong>\r\n<ul>\r\n<li>At least 10% ABER is recommended in endemic areas to ensure effective detection.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Significance:</strong>\r\n<ul>\r\n<li>Directly measures service delivery efficiency rather than disease burden.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Annual parasite index (Option A):</strong> API measures malaria transmission intensity by the number of positive malaria cases per 1,000 population per year. It is an epidemiological index, not an operational efficiency measure.</p>\r\n<p><strong>Slide positivity rate (Option B):</strong> SPR is the percentage of blood slides found positive for malaria among total slides examined. It indicates malaria prevalence among suspected cases but does not measure service coverage.</p>\r\n<p><strong>Slide falciparum rate (Option C):</strong> SFR is the proportion of slides positive for Plasmodium falciparum. It reflects the distribution of falciparum malaria but is not a measure of operational efficiency.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Mefloquine</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate + sulphadoxine-pyrimethamine</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Artemether + lumefantrine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The drug of choice for the treatment of Plasmodium falciparum malaria in the north-eastern states of India is -</span></p>",
      "unique_key": "DT1231407",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231407,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The north-eastern states of India have a higher prevalence of P. falciparum malaria with distinct drug resistance patterns. To address these, the recommended first-line treatment is Artemether + lumefantrine (AL), an artemisinin-based combination therapy (ACT).</p>\r\n<ul>\r\n<li><strong>Mechanism:</strong> AL combines the rapid parasite clearance of artemether with the prolonged action of lumefantrine to reduce recurrence.</li>\r\n<li><strong>Advantages:</strong>\r\n<ul>\r\n<li>Effective against drug-resistant P. falciparum strains.</li>\r\n<li>Short treatment course (3 days).</li>\r\n<li>Reduces gametocyte carriage, limiting transmission.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Dosage:</strong> In NE states, treatment is given as age-specific ACT-AL for 3 days.</li>\r\n<li><strong>Rationale for use in NE states:</strong> Sulphadoxine-pyrimethamine resistance is high; hence AS+SP is avoided.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Mefloquine (Option A):</strong> An effective antimalarial but not the preferred first-line in NE states due to potential resistance and CNS-related adverse effects. Used more for prophylaxis or in combination therapy elsewhere.</p>\r\n<p><strong>Artesunate + sulphadoxine-pyrimethamine (Option B):</strong> Previously used as first-line in many Indian states, but discontinued in NE states due to high SP resistance rates.</p>\r\n<p><strong>Doxycycline (Option D):</strong> Not used as a first-line drug for uncomplicated malaria. Primarily used as prophylaxis or in combination therapy for severe malaria, especially in adults, when artemisinin derivatives or quinine are also given.</p>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinine</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">ACT</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Primaquine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">DOC for treatment of Plasmodium falciparum in the 1st trimester of pregnancy -</span></p>",
      "unique_key": "DT1231408",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231408,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Quinine is the drug of choice for the treatment of Plasmodium falciparum malaria in the first trimester of pregnancy. It is preferred in this period because of its established safety profile for both the mother and the developing fetus.</p>\r\n<ul>\r\n<li><strong>First trimester consideration:</strong> Artemisinin-based Combination Therapy (ACT) is avoided in the first trimester due to limited safety data, despite its high efficacy.</li>\r\n<li><strong>Role of quinine:</strong> Safe for pregnant women in the first trimester and effective against Plasmodium falciparum in areas with chloroquine resistance.</li>\r\n<li><strong>Public health relevance:</strong> Prevents progression to severe malaria, which is more likely in pregnancy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>ACT (Option B):</strong> Artemisinin-based Combination Therapy is recommended in later trimesters but avoided in the first trimester unless no alternatives are available, due to limited safety evidence.</p>\r\n<p><strong>Chloroquine (Option C):</strong> Not effective for Plasmodium falciparum in most endemic regions due to widespread resistance; not the preferred choice in the first trimester.</p>\r\n<p><strong>Primaquine (Option D):</strong> Used for radical cure of Plasmodium vivax and Plasmodium ovale by eliminating hypnozoites; contraindicated in pregnancy due to risk of hemolysis in G6PD-deficient fetus and not indicated for Plasmodium falciparum.</p>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">G6PD deficiency</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Infants</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Primaquine is contraindicated in -</span></p>",
      "unique_key": "DT1231409",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231409,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Primaquine is an antimalarial drug used for the radical cure of Plasmodium vivax and Plasmodium ovale malaria. It is contraindicated in certain groups due to the risk of severe adverse effects.</p>\r\n<ul>\r\n<li><strong>Pregnancy:</strong> Avoided due to potential harm to the foetus and lack of safety data; safer alternatives preferred.</li>\r\n<li><strong>G6PD deficiency:</strong> Risk of haemolysis and haemolytic anaemia; testing is essential before use.</li>\r\n<li><strong>Infants:</strong> Immature metabolic pathways increase the risk of drug toxicity; contraindicated in this age group.</li>\r\n</ul>\r\n<p>Thus, option <strong>D</strong> is correct as primaquine is contraindicated in all the above groups.</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">100 mg/week</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">200 mg/week</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">250 mg/week</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">300 mg/week</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Chemoprophylaxis with mefloquine includes -</span></p>",
      "unique_key": "DT1231410",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231410,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The recommended adult dose of mefloquine for malaria chemoprophylaxis is <strong>250 mg once weekly</strong>. This dose maintains effective blood concentrations to prevent malaria in travelers to endemic areas.</p>\r\n<ul>\r\n<li><strong>Definition:</strong> Chemoprophylaxis refers to the administration of antimalarial drugs to prevent infection in individuals at risk.</li>\r\n<li><strong>Mefloquine use:</strong> Effective in areas with chloroquine-resistant Plasmodium falciparum.</li>\r\n<li><strong>Adult regimen:</strong> 250 mg base (one tablet) once weekly, starting 2-3 weeks before travel to endemic areas and continued for 4 weeks after leaving the area.</li>\r\n<li><strong>Advantages:</strong> Convenient weekly dosing; suitable for long-term prophylaxis in selected individuals.</li>\r\n<li><strong>Precautions:</strong> Contraindicated in those with a history of psychiatric disorders, epilepsy, or cardiac conduction defects.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>100 mg/week (Option A):</strong> Lower than the recommended dose; inadequate to maintain protective blood levels, increasing malaria risk.</p>\r\n<p><strong>200 mg/week (Option B):</strong> Still sub-therapeutic and insufficient for reliable protection.</p>\r\n<p><strong>300 mg/week (Option D):</strong> Exceeds the recommended dose; may raise the risk of adverse effects without added protective benefit.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Early treatment of case</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemoprophylaxis</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Vector control</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Elimination of Plasmodium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most important strategy for control of malaria in endemic areas is-</span></p>",
      "unique_key": "DT1231411",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231411,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Vector control is the most important strategy for controlling malaria in endemic areas, as it directly targets the mosquito vectors responsible for transmission, thereby breaking the cycle of infection.</p>\r\n<ul>\r\n<li><strong>Definition:</strong> Vector control refers to interventions aimed at reducing mosquito populations, particularly Anopheles species, which are the primary vectors for malaria.</li>\r\n<li><strong>Rationale:</strong> By controlling vectors, the transmission of the malaria parasite is significantly reduced, preventing new infections and lowering community parasite load.</li>\r\n<li><strong>Key measures:</strong>\r\n<ul>\r\n<li><strong>Indoor Residual Spraying (IRS):</strong> Spraying insecticides such as DDT, malathion, or synthetic pyrethroids on interior walls to kill mosquitoes resting indoors.</li>\r\n<li><strong>Insecticide-Treated Nets (ITNs) and Long-Lasting Insecticidal Nets (LLINs):</strong> Protection from mosquito bites during sleeping hours.</li>\r\n<li><strong>Larval Source Management:</strong> Elimination of mosquito breeding sites, including drainage of stagnant water and environmental sanitation.</li>\r\n<li><strong>Biological Control:</strong> Use of larvivorous fish in water bodies to reduce mosquito larvae.</li>\r\n<li><strong>Personal Protection Measures:</strong> Use of repellents, protective clothing, and screened housing.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Effectiveness:</strong> These strategies reduce both mosquito density and human-vector contact, leading to significant reductions in malaria transmission rates.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Early treatment of case (Option A):</strong> Essential for reducing disease severity and mortality but does not interrupt transmission, as untreated mosquito vectors can still spread the parasite.</p>\r\n<p><strong>Chemoprophylaxis (Option B):</strong> Useful for travelers or special populations at high risk, but impractical for mass application in endemic areas due to cost, compliance issues, and potential for drug resistance.</p>\r\n<p><strong>Elimination of Plasmodium (Option D):</strong> The ultimate goal of malaria control programs, but it requires multiple strategies including vector control, case management, and surveillance. It is a long-term and challenging objective, not an immediate control measure.</p>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">IEC campaigns for community awareness</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Insecticide-treated bed nets</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Development of larvivorous fish or eradication of larvae</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Presumptive treatment of malaria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The Roll Back Malaria program focused mainly on-</span></p>",
      "unique_key": "DT1231412",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231412,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The Roll Back Malaria (RBM) initiative was launched in 1998 by WHO, UNDP, UNICEF, and the World Bank with the goal of reducing malaria-related morbidity and mortality worldwide. While it employs a range of strategies, its primary emphasis is on the widespread use of insecticide-treated bed nets (ITNs).</p>\r\n<ul>\r\n<li><strong>Insecticide-treated bed nets (ITNs):</strong>\r\n<ul>\r\n<li>Provide both a physical barrier against mosquito bites and a chemical barrier through insecticide treatment.</li>\r\n<li>Proven to reduce malaria transmission significantly in endemic areas.</li>\r\n<li>Core intervention in RBM's strategy to reduce disease burden.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Additional RBM strategies:</strong>\r\n<ul>\r\n<li>Strengthening health systems for prompt diagnosis and effective treatment.</li>\r\n<li>Enhancing community participation and awareness.</li>\r\n<li>Integrated vector management, including larval control and environmental measures.</li>\r\n<li>Cross-border collaboration and targeted interventions in high-transmission areas.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>IEC campaigns for community awareness (Option A):</strong> Important for mobilising community participation, but considered supportive rather than the main intervention in RBM.</p>\r\n<p><strong>Development of larvivorous fish or eradication of larvae (Option C):</strong> Part of integrated vector management, useful in specific ecological settings, but not the primary focus of RBM.</p>\r\n<p><strong>Presumptive treatment of malaria (Option D):</strong> Previously common in areas without diagnostic facilities, but RBM promotes confirmed diagnosis before treatment to prevent drug resistance and ensure appropriate case management.</p>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">DENV-1/DENV-2</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">DENV-3/DENV-2</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">DENV-4/DENV-2</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">All have equal risk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The sequence of infection posing the highest risk of dengue hemorrhagic fever is-</span></p>",
      "unique_key": "DT1231413",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231413,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Severe dengue manifestations such as dengue hemorrhagic fever (DHF) are more likely in secondary infections with a different dengue virus serotype due to <strong>antibody-dependent enhancement (ADE)</strong>. In ADE, non-neutralising antibodies from the primary infection enhance viral entry and replication in subsequent infections.</p>\r\n<ul>\r\n<li>Evidence from studies, including those in Thailand, shows that infection with <strong>DENV-1 followed by DENV-2</strong> is strongly associated with a high risk of DHF, about a 60-fold increased risk compared with primary infection.</li>\r\n<li>Similarly, a <strong>DENV-3/DENV-2</strong> sequence carries a high risk (about 145-fold), but DENV-1/DENV-2 remains a well-recognised high-risk sequence in epidemiological data.</li>\r\n<li>The phenomenon underscores the importance of serotype-specific immunity in disease severity.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>DENV-3/DENV-2 (Option B):</strong> Associated with an increased risk of DHF, but epidemiological data indicate DENV-1 followed by DENV-2 is more strongly linked to severe outcomes.</p>\r\n<p><strong>DENV-4/DENV-2 (Option C):</strong> Can lead to DHF through ADE, but has less evidence of high relative risk compared with DENV-1/DENV-2.</p>\r\n<p><strong>All have equal risk (Option D):</strong> Incorrect, as risk varies with sequence; not all serotype combinations have the same epidemiological risk level.</p>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}